RE:RE:RE:Big Pharma is facing a looming $236 Billion patent cliff
I agree with you aobut the exclusivity but the problem I am having is that the company needs to have product approval before the patents expire and Matt even suggested as much at the recent presentation. So that is my worry if anything is delayed or the trial takes longer than expected, that would bring us very close to the expiration of the composition of matter patent but at this time we do not know when all of the other patents start to expire and as I mentioned, onc lost 60 patents in just the last quarter which I do not take as a good sign of the patent portfolio. That is why I am hoping that a deal can be done sooner than later and really think that a buyout would be the best protection for the company in the long run